Claire Teague,^a Elaine Holmes,^a Elaine Maibaum,^a Jeremy Nicholson,^a Huiru Tang,^a Queenie Chan,^b Paul Elliott,^b Jeremiah Stamler,^c Hirotsugu Ueshima,^d Beifan Zhou^e and Ian Wilson*^af

Analyst, 2004, 129, 259 (DOI: 10.1039/b314316n). Amendment published 19th April 2004

The authors for this paper should be as above with the following affiliations:

^a Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London, UK SW7 2AZ

^b Department of Epidemiology and Public Health, Imperial College London, St Mary’s, London, UK

^c Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

^d Department of Health Science, Shiga University of Medical Science, Otsu, Japan

^e Department of Epidemiology, Fu Wai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

^f Drug Metabolism and Pharmacokinetics Department, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, UK SK10 4TG. Email: Ian.Wilson@astrazeneca.com

The Acknowledgements should also be corrected as follows: We thank Unilever for their financial support (C. Teague). We are grateful to the INTERMAP consortium for financial support (E. Maibaum, NIH INTERMAP Metabonomics Grant 05 R01-HL071950-2). The INTERMAP study was supported by Grant 2-RO1-HL50490 from the US National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA, as well as national and local agencies in the four countries.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Back